Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible and health & bio startups. Verve Ventures provides it’s pan-European network of selected private and institutional investors access to those top tier investment opportunities. The company invests from EUR 500k to several million from Seed to Series B and beyond across Europe. Verve Ventures’ dedicated team helps startups with their most pressing needs such as hiring, client introductions and access to an expert network of high-profile individuals. To become part of Verve Ventures’ growing network of entrepreneurs and investors, visit verve.vc.
Verve Ventures
Similar companies
Fåhraeus Startup & Growth
Fåhraeus Startup and Growth Fund was started in 2021 by Christer Fåhraeus and Emanuel Eriksson. It is a Venture Capital fund focusing on investing early in companies in life science and tech. The goal of the investments is to take the companies up for sale or listing on the stock exchange a few years after the investment. Christer and Emanuel, together with Linus Wiebe, manage the fund. History of the fund In recent years, Christer Fåhraeus and Emanuel Eriksson have worked together with investments in small listed companies and unlisted life science and tech companies for Fårö Capital. Fårö Capital is a Family Office fund where Christer has been CEO and Emanuel Investment Manager. During the years at Fårö Capital, they decided to raise a fund for investments in companies in the same industry with excellent growth potential. Sustainability Fåhraeus Startup & Growth has integrated sustainability risks into the investment decision process at all stages of the investment life cycle. Sustainability risks include environmental, social or governance-related events or circumstances that may have a significant adverse effect on the value of the investment. The risks are initially assessed together with other types of risks as part of the due diligence work before the investment takes place. The various factors are prioritized depending on how important they are for the business, the stakeholders and the expected effect on the investment. A conclusion that there are significant sustainability risks that will not be manageable or limited results in a decision not to invest. Fåhraeus Startup & Growth does not consider the main negative consequences of investment decisions for sustainability factors because, given the fund’s size and investment strategy, it is not possible to carry out reliable due diligence from a cost-benefit perspective. However, the fund continues to evaluate and consider its obligations regarding the investments’ main negative consequences for sustainability factors. Decisions and publications can be reviewed once the technical standards have been adopted and when data and tools for measuring the significant negative consequences regarding unlisted life science and technology companies have been developed and become more efficient. Before making an investment decision, the long-term effects of the investment are taken into account, and the fund avoids taking short-term risks to achieve a profit.
Inhite Ventures
We have a long-term interest in innovation, disruptive technology, and the entrepreneurs that lead their companies from early stage to sustainable growth. We have been operators in building technology products, teams, and companies since the early days of the internet and in the technology sector for over twenty-five (25) years, and pursuing innovative and scalable technology companies for strategic investments; opportunities that converge leading-edge technology and meaningful purpose together to create enduring products and services that make our lives better and our world safer for generations. The meaning behind "inhite" - \ in·hite \ - ˈ [ in ]·[ h AY t ] ˈ - we are into high tech ventures, and we make investments in healthcare innovation and technology endeavors, targeting Healthcare Artificial Intelligence (AI) growth startup companies. @inhite, we are focused on supporting creative founders, entrepreneurs, that are inspired by innovation and technology and can innovate technology products that can provide efficient and effective services to market while generating sustainable and ongoing growth for years to come. Having been there and done that ourselves, we add operating experience and strategic capital to portfolio companies. We seek to support founders who are building scalable companies that possess recurring revenues, strong technical barriers, and competitive advantages in the market in which the teams possess the driving force and in sync with us through the process.
Lunar Ventures
We are technical investors, partnering with technical founders, who are building at the intersection of DeepTech and software. We bring a fresh perspective into tech investments: leveraging our own backgrounds in software architecture, computer science, business strategy, and early stage investments. If you’re a technical founder who's struggled to explain your tech and vision to investors, we set up a fund for you. We invest pre-revenue to help turn your science fiction into reality. We care about your code, not your sales pipeline. We like to work with founders as early as we can: €300K - €1M initial investment into technical teams with strong R&D backgrounds building with ♥ in Europe products that will sell globally
Forestay Capital
We support start-ups with investments between $10M and $20M in Europe, Israel and opportunistically on the East coast of the US. Forestay is more than just a VC fund, it’s a family. Forestay was founded as the digital tech arm of a family-oriented investment group that traces its successes in business and its enduring values back across generations. The Bertarelli family founded B-FLEXION (formerly Waypoint Capital), of which Forestay is a part, in 2012 to evolve the management of the capital realised by the sale of Serono, the global leader in biotech and healthcare that they had grown over three generations of leadership. In the decade since, B-FLEXION and its businesses have generated exceptional and lasting value. B-FLEXION is an entrepreneurial private investment firm that partners with sophisticated capital to deliver exceptional value over the generations. As well as its investment funds seeding and building businesses in technology, private equity, real estate and hedge funds, B-FLEXION also focuses on growing operating businesses in transformative industries. Building on its heritage and of that of its founder and Chairman, these have been principally in life sciences, healthcare and digital health.
LiquidMetal Ventures
LiquidMetal Ventures is a newly established venture capital fund based in Boston, aiming at investing in early-stage (Seed, Angel, and pre-A round) in a minority group, particularly deep-tech startups. LiquidMetal Ventures is based on deep-tech start-up communities and has a unique advantage in reaching out to ‘off-the-market’ early-stage deals and cooperating with peer VC funds tightly to reduce the risk, overall a high return could be expected. LiquidMetal Ventures focuses on biotech and healthcare, carbon neutrality, AI and data, infrastructure, and consumer tech. There is a huge tide of startups among Boston entrepreneurs in the US on the way. We would like to be the first to check VC with the founders. Investment FocusBioTech Medical Device Sustainability AI & Data Science Advanced Energy Technology Robotics & Advanced Manufacturing
Onsight Ventures
Investing in groundbreaking technologies means actively shaping the future. Passion is what drives us. Look deeper is our approach. About Onsight Ventures Think globally, act locally. We bring together bright minds to create technologies that have a global impact. Based in Innsbruck, Onsight Ventures is setting new momentum for high-tech start-ups in Austria and Europe. Supported by founding partners Hermann Hauser Investment, Round2 Capital, I.E.C.T., and Standortagentur Tirol, Onsight Ventures builds on a Europe-wide network of industry leading start-ups, universities and experts, to work closely with and support outstanding management teams in the implementation of their technology-based business ideas. Our vision – to work with tomorrow's most outstanding entrepreneurs today. Our goal – to support the development of young companies in reaching their goals and thus partake in actively shaping the future. Our core valuesAmbition: BioNTech, a company largely unknown before the COVID crisis, is making history. This has been achieved following the founding of a successful spin-off, led by three physicians - including Tyrolean Christoph Huber, a member of the Onsight advisory board. Excellence: We don't have to look to Silicon Valley or China for inspiration or knowledge; here in Europe we have excellent university and non-institute-based research.There is no lack of innovation. Convinced by their potential, our sweet spot is academic start-ups and university spin-offs. Impact: The 21st century is presenting us and our planet with major challenges. We are convinced that young entrepreneurs can achieve a positive impact with their technologies and business models by pursuing their goals with passion. Our responsibility as an investor is to help sustainable technologies grow both capital and know-how. Integrity: Entrepreneurship is a team sport. The road to building an internationally successful company is a rocky one. That's why trust, honesty and integrity play a crucial role in the long-term cooperation between founder teams and investors.